Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Histologic findings associated with false-positive multiparametric magnetic resonance imaging performed for prostate cancer detection.

Gordetsky JB, Ullman D, Schultz L, Porter KK, Del Carmen Rodriguez Pena M, Calderone CE, Nix JW, Ullman M, Bae S, Rais-Bahrami S.

Hum Pathol. 2019 Jan;83:159-165. doi: 10.1016/j.humpath.2018.08.021. Epub 2018 Sep 1.

PMID:
30179687
2.

Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes.

Meng X, Rosenkrantz AB, Mendhiratta N, Fenstermaker M, Huang R, Wysock JS, Bjurlin MA, Marshall S, Deng FM, Zhou M, Melamed J, Huang WC, Lepor H, Taneja SS.

Eur Urol. 2016 Mar;69(3):512-7. doi: 10.1016/j.eururo.2015.06.005. Epub 2015 Jun 22.

3.

The Role of Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Biopsy in Active Surveillance.

Ma TM, Tosoian JJ, Schaeffer EM, Landis P, Wolf S, Macura KJ, Epstein JI, Mamawala M, Carter HB.

Eur Urol. 2017 Feb;71(2):174-180. doi: 10.1016/j.eururo.2016.05.021. Epub 2016 May 25.

PMID:
27236496
4.

A prospective study of magnetic resonance imaging and ultrasonography (MRI/US)-fusion targeted biopsy and concurrent systematic transperineal biopsy with the average of 18-cores to detect clinically significant prostate cancer.

Hakozaki Y, Matsushima H, Kumagai J, Murata T, Masuda T, Hirai Y, Oda M, Kawauchi N, Yokoyama M, Homma Y.

BMC Urol. 2017 Dec 12;17(1):117. doi: 10.1186/s12894-017-0310-7.

5.
6.

Additional value of magnetic resonance-targeted biopsies to standard transrectal ultrasound-guided biopsies for detection of clinically significant prostate cancer.

von Below C, Wassberg C, Norberg M, Tolf A, Kullberg J, Ladjevardi S, Häggman M, Bill Axelson A, Ahlström H.

Scand J Urol. 2017 Apr;51(2):107-113. doi: 10.1080/21681805.2017.1281346. Epub 2017 Feb 24.

PMID:
28635568
7.

Detection of extraprostatic disease and seminal vesicle invasion in patients undergoing magnetic resonance imaging-targeted prostate biopsies.

Baumgartner EM, Porter KK, Nix JW, Rais-Bahrami S, Gordetsky JB.

Transl Androl Urol. 2018 Sep;7(Suppl 4):S392-S396. doi: 10.21037/tau.2018.03.15.

8.

Prebiopsy MRI and MRI-ultrasound Fusion-targeted Prostate Biopsy in Men With Previous Negative Biopsies: Impact on Repeat Biopsy Strategies.

Mendhiratta N, Meng X, Rosenkrantz AB, Wysock JS, Fenstermaker M, Huang R, Deng FM, Melamed J, Zhou M, Huang WC, Lepor H, Taneja SS.

Urology. 2015 Dec;86(6):1192-8. doi: 10.1016/j.urology.2015.07.038. Epub 2015 Aug 31.

9.

Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.

Radtke JP, Schwab C, Wolf MB, Freitag MT, Alt CD, Kesch C, Popeneciu IV, Huettenbrink C, Gasch C, Klein T, Bonekamp D, Duensing S, Roth W, Schueler S, Stock C, Schlemmer HP, Roethke M, Hohenfellner M, Hadaschik BA.

Eur Urol. 2016 Nov;70(5):846-853. doi: 10.1016/j.eururo.2015.12.052. Epub 2016 Jan 19.

PMID:
26810346
10.

Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy in a Consecutive Cohort of Men with No Previous Biopsy: Reduction of Over Detection through Improved Risk Stratification.

Mendhiratta N, Rosenkrantz AB, Meng X, Wysock JS, Fenstermaker M, Huang R, Deng FM, Melamed J, Zhou M, Huang WC, Lepor H, Taneja SS.

J Urol. 2015 Dec;194(6):1601-6. doi: 10.1016/j.juro.2015.06.078. Epub 2015 Jun 19.

PMID:
26100327
11.

The value of magnetic resonance imaging and ultrasonography (MRI/US)-fusion biopsy platforms in prostate cancer detection: a systematic review.

Gayet M, van der Aa A, Beerlage HP, Schrier BP, Mulders PF, Wijkstra H.

BJU Int. 2016 Mar;117(3):392-400. doi: 10.1111/bju.13247. Epub 2015 Aug 28. Review.

12.

MRI-Ultrasound Fusion Targeted Biopsy of Prostate Imaging Reporting and Data System Version 2 Category 5 Lesions Found False-Positive at Multiparametric Prostate MRI.

Sheridan AD, Nath SK, Aneja S, Syed JS, Pahade J, Mathur M, Sprenkle P, Weinreb JC, Spektor M.

AJR Am J Roentgenol. 2018 May;210(5):W218-W225. doi: 10.2214/AJR.17.18680. Epub 2018 Feb 28.

PMID:
29489409
13.

Multi-institutional nomogram predicting benign prostate pathology on magnetic resonance/ultrasound fusion biopsy in men with a prior negative 12-core systematic biopsy.

Truong M, Wang B, Gordetsky JB, Nix JW, Frye TP, Messing EM, Thomas JV, Feng C, Rais-Bahrami S.

Cancer. 2018 Jan 15;124(2):278-285. doi: 10.1002/cncr.31051. Epub 2017 Oct 4.

14.

Magnetic Resonance Imaging-Ultrasound Fusion Biopsy During Prostate Cancer Active Surveillance.

Tran GN, Leapman MS, Nguyen HG, Cowan JE, Shinohara K, Westphalen AC, Carroll PR.

Eur Urol. 2017 Aug;72(2):275-281. doi: 10.1016/j.eururo.2016.08.023. Epub 2016 Aug 29.

PMID:
27595378
15.

Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy--prospective multicenter study.

Puech P, Rouvière O, Renard-Penna R, Villers A, Devos P, Colombel M, Bitker MO, Leroy X, Mège-Lechevallier F, Comperat E, Ouzzane A, Lemaitre L.

Radiology. 2013 Aug;268(2):461-9. doi: 10.1148/radiol.13121501. Epub 2013 Apr 11.

PMID:
23579051
16.

Prostate cancer detection on transrectal ultrasonography-guided random biopsy despite negative real-time magnetic resonance imaging/ultrasonography fusion-guided targeted biopsy: reasons for targeted biopsy failure.

Cash H, Günzel K, Maxeiner A, Stephan C, Fischer T, Durmus T, Miller K, Asbach P, Haas M, Kempkensteffen C.

BJU Int. 2016 Jul;118(1):35-43. doi: 10.1111/bju.13327. Epub 2015 Oct 20.

17.

Free-hand transperineal targeted prostate biopsy with real-time fusion imaging of multiparametric magnetic resonance imaging and transrectal ultrasound: single-center experience in China.

Zhang Q, Wang W, Yang R, Zhang G, Zhang B, Li W, Huang H, Guo H.

Int Urol Nephrol. 2015 May;47(5):727-33. doi: 10.1007/s11255-015-0957-5. Epub 2015 Mar 29.

PMID:
25820744
18.

Predictive Parameters Identifying Men Eligible for a Sole MRI/Ultrasound Fusion-Guided Targeted Biopsy without an Additional Systematic Biopsy.

Günzel K, Haas M, Maxeiner A, Stephan C, Buckendahl J, Asbach P, Miller K, Kempkensteffen C, Cash H.

Urol Int. 2017;98(1):15-21. doi: 10.1159/000449258. Epub 2016 Sep 13.

PMID:
27618633
19.

A Randomized Controlled Trial To Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy.

Baco E, Rud E, Eri LM, Moen G, Vlatkovic L, Svindland A, Eggesbø HB, Ukimura O.

Eur Urol. 2016 Jan;69(1):149-56. doi: 10.1016/j.eururo.2015.03.041. Epub 2015 Apr 7.

20.

Prospective Evaluation of the Prostate Imaging Reporting and Data System Version 2 for Prostate Cancer Detection.

Mertan FV, Greer MD, Shih JH, George AK, Kongnyuy M, Muthigi A, Merino MJ, Wood BJ, Pinto PA, Choyke PL, Turkbey B.

J Urol. 2016 Sep;196(3):690-6. doi: 10.1016/j.juro.2016.04.057. Epub 2016 Apr 18.

PMID:
27101772

Supplemental Content

Support Center